Neurology Medical News about Glioma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Imaging response criteria for recurrent gliomas treated with bevacizumab: Role of diffusion weighted imaging as an imaging biomarker
Journal of Neuro-Oncology, 11/03/09

Jain R et al. – CELADC and NELADC appear to follow different trends over time for non–progressors and progressors with a stable to slightly progressive increase in non–progressors and a progressive decrease in progressors, especially early on. These findings suggest that DWI may be used as an additional imaging biomarker for early treatment response.

<< Previous
Disease progression among multiple sclerosis patients before and...

Next >>
Neurological symptoms in patients with biopsy proven celiac...

Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1
Journal of Neuro-Oncology, 11/19/09 Relevance Score: 90%

Height, Body Mass Index, and Physical Activity in Relation to Glioma Risk
Cancer Research, 11/02/09 Relevance Score: 90%

Diagnostic and prognostic markers in gliomas
Current Opinion in Oncology, 10/13/09 Relevance Score: 90%

Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches
Current Opinion in Neurology, 11/11/09 Relevance Score: 89%

Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy
International Journal of Cancer, 11/10/09 Relevance Score: 89%